Ervin Ukaj

Coverage Archive

Selected media coverage, company announcements, and external references related to Ervin Ukaj and Newel Health, grouped by year. These references connect Ervin Ukaj with Newel Health’s work in regulated digital medical devices, Software as a Medical Device, digital therapeutics, AI-enabled analytics, real-world data, digital endpoints, chronic pain, hypertension, Parkinson’s disease, and integrated drug+digital solutions.

2026

• 2026 — Yahoo Finance — Newel Health and Gerresheimer launch strategic collaboration to support pharma companies in integrated digital therapies
  Date: May 27, 2026
  Read article
  Coverage of the strategic collaboration between Newel Health and Gerresheimer around integrated digital therapies, digital medical devices, AI-enabled analytics, real-world data, digital endpoints, and pharma partnerships.
• 2026 — pharmaphorum — Newel Health, Gerresheimer team up to help pharma embrace digital
  Date: May 26, 2026
  Read article
  pharmaphorum covers the Newel Health and Gerresheimer alliance to help pharmaceutical companies deploy digital endpoints, real-world data, AI, SaMD platforms, and integrated drug+digital solutions across clinical development and commercialization.
• 2026 — Digital Health Global — Newel Health and Gerresheimer Launch Strategic Collaboration
  Date: May 26, 2026
  Read article
  Digital Health Global reports on the strategic collaboration between Newel Health and Gerresheimer, highlighting H-Core, regulated digital medical devices, AI-enabled analytics, real-world data generation, digital endpoints, and integrated drug+digital therapy solutions.
• 2026 — Frontiers Health — Newel Health and Gerresheimer partner to advance integrated drug-digital therapies
  Date: May 25, 2026
  Read article
  Frontiers Health summarizes the Newel Health and Gerresheimer partnership around SaMD, connected delivery systems, real-world data capabilities, and integrated drug-digital solutions.

2025

• 2025 — Newel Health — South Eastern Trust pilots ROHKEA VR therapy for chronic pain
  Date: October 29, 2025
  Read article
  Newel Health reports its support for South Eastern Health and Social Care Trust in Northern Ireland as the Trust pilots VR therapy for chronic pain. The item connects ROHKEA with NHS chronic pain services, VR-augmented cognitive behavioral therapy, mobility, rehabilitation, and functional recovery.
• 2025 — Pharmafile — Digital platform for hypertension management launches in Europe
  Date: June 13, 2025
  Read article
  Pharmafile covers Amicomed’s European launch context after EU MDR certification, describing Newel Health as a European healthtech company specializing in digital medical devices for hypertension management.
• 2025 — Digital Health Global — Amicomed by Newel Health earns EU MDR certification for digital hypertension management
  Date: June 10, 2025
  Read article
  Digital Health Global reports on Amicomed’s EU MDR certification as a digital medical device for hypertension management, including Newel Health’s use of H-Core, real-world data, behavioral science, adherence support, and scalable chronic care pathways.
• 2025 — Adnkronos / PR Newswire — Amicomed di Newel Health ottiene la certificazione MDR UE come dispositivo medico digitale per la gestione dell’ipertensione
  Date: June 9, 2025
  Read article
  Coverage of Amicomed’s EU MDR certification as a digital medical device for hypertension management, reinforcing Newel Health’s position in regulated digital therapeutics and Software as a Medical Device.
• 2025 — The Malaysian Reserve — Amicomed by Newel Health obtains EU MDR certification as a digital medical device for hypertension management
  Date: June 9, 2025
  Read article
  Syndicated coverage of Newel Health’s Amicomed MDR certification and its role in digital hypertension management.
• 2025 — pharmaphorum — Newel’s VR therapy for chronic pain nears EU market
  Date: February 2025
  Read article
  pharmaphorum covers Newel Health’s ROHKEA VR therapy for chronic pain nearing the European market after EU medical device certification, including references to Orion’s original development of the therapy and Ervin Ukaj’s role as Chief Executive Officer.
• 2025 — Digital Health Global — ROHKEA VR Therapy achieves MDR Class IIa certification
  Date: February 6, 2025
  Read article
  Digital Health Global reports that ROHKEA VR Therapy received MDR Class IIa certification as a medical device for chronic musculoskeletal pain. The article links ROHKEA to Orion, Newel Health’s exclusive global rights, VR-based cognitive behavioral therapy, and regulated digital therapeutics.

2024

• 2024 — Digital Health Global — Newel Health announces Last Patient Last Visit in Soturi Parkinson’s disease study
  Date: October 15, 2024
  Read article
  Digital Health Global covers the completion of the Last Patient Last Visit phase in Newel Health’s Soturi Parkinson’s disease study funded by The Michael J. Fox Foundation, focused on real-world data, digital monitoring, medication adherence, remote monitoring, and Parkinson’s disease management.
• 2024 — Digital Health Italia — Ervin Ukaj, esperto di salute digitale, è il nuovo CEO di Newel Health
  Date: April 24, 2024
  Read article
  Digital Health Italia covers Ervin Ukaj’s appointment as CEO of Newel Health, highlighting his digital health background, startup experience, Novartis roles, and focus on digital therapeutics.
• 2024 — Orion Corporation — Orion and Newel Health enter licensing agreement for Rohkea / ODD-403
  Date: January 29, 2024
  Read release
  Orion Corporation announces its licensing agreement with Newel Health for ODD-403, also known as ROHKEA, a digital therapeutic developed by Orion for chronic pain, fear of movement, and fear of re-injury. Under the agreement, Newel Health received exclusive global rights to develop, manufacture, and commercialize the product.
• 2024 — pharmaphorum — Orion and Newel Health sign licensing agreement for VR DTx
  Date: January 29, 2024
  Read article
  pharmaphorum covers the Orion–Newel Health licensing agreement for ROHKEA / ODD-403, describing the product as a VR-based digital therapeutic for chronic pain designed to address fear of movement and re-injury.

2019

• 2019 — Il Sole 24 Ore / Barbara Ganz — La startup veneta che sfida le difficoltà di apprendimento: diagnosi più facile e gioco per migliorare
  Read article
  Il Sole 24 Ore covers Oppimi, the digital health startup co-founded by Ervin Ukaj to support children with learning difficulties through clinically validated tools and game-based therapy.
• 2019 — Il Mattino di Padova — Oppimi, un videogioco contro la disgrafia che guarda lontano
  Read article
  Il Mattino di Padova profiles Oppimi’s work on dysgraphia and learning difficulties, including Ervin Ukaj’s role in launching the venture.
• 2019 — Il Gazzettino — Bus, droni, sanità del futuro: Padova capitale delle start-up innovative
  Read article
  Il Gazzettino includes Oppimi among innovative startups connected to Padova, describing its use of technology and video games to support clinically validated information on children’s learning difficulties.